WO2006117211A3 - Derives d'uree, procedes pour leur fabrication et utilisations de ces derives - Google Patents
Derives d'uree, procedes pour leur fabrication et utilisations de ces derives Download PDFInfo
- Publication number
- WO2006117211A3 WO2006117211A3 PCT/EP2006/004166 EP2006004166W WO2006117211A3 WO 2006117211 A3 WO2006117211 A3 WO 2006117211A3 EP 2006004166 W EP2006004166 W EP 2006004166W WO 2006117211 A3 WO2006117211 A3 WO 2006117211A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- manufacture
- urea derivatives
- derivatives methods
- methods
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Treating Waste Gases (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT06724709T ATE548368T1 (de) | 2005-04-29 | 2006-04-24 | Harnstoffderivate, verfahren zu ihrer herstellung und ihre anwendungen |
AU2006243328A AU2006243328B2 (en) | 2005-04-29 | 2006-04-24 | Urea derivatives methods for their manufacture and uses thereof |
EP06724709A EP1874765B1 (fr) | 2005-04-29 | 2006-04-24 | Derives d'uree, procedes pour leur fabrication et utilisations de ces derives |
BRPI0611025A BRPI0611025A2 (pt) | 2005-04-29 | 2006-04-24 | composto, uso de um composto, e, composição farmacêuticamente aceitável |
ES06724709T ES2384052T3 (es) | 2005-04-29 | 2006-04-24 | Derivados de urea, métodos para su fabricación y usos de los mismos |
EA200702375A EA200702375A1 (ru) | 2005-04-29 | 2006-04-24 | Производные мочевины, способы их получения и применения |
JP2008508167A JP4995189B2 (ja) | 2005-04-29 | 2006-04-24 | 尿素誘導体、その製造方法、およびその使用 |
CA002605008A CA2605008A1 (fr) | 2005-04-29 | 2006-04-24 | Derives d'uree, procedes pour leur fabrication et utilisations de ces derives |
US11/919,537 US8247412B2 (en) | 2005-04-29 | 2006-04-24 | Urea derivatives methods for their manufacture and uses thereof |
PL06724709T PL1874765T3 (pl) | 2005-04-29 | 2006-04-24 | Pochodne mocznika, sposoby ich otrzymywania i zastosowanie |
DK06724709.8T DK1874765T3 (da) | 2005-04-29 | 2006-04-24 | Ureaderivater, fremgangsmåder til fremstilling af disse og anvendelser deraf |
IL186854A IL186854A0 (en) | 2005-04-29 | 2007-10-23 | Urea derivatives and pharmaceutical compositions containing the same |
NO20076145A NO20076145L (no) | 2005-04-29 | 2007-11-28 | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav |
HRP20120424TT HRP20120424T1 (hr) | 2005-04-29 | 2012-05-17 | Derivati ureje, postupci za njihovu proizvodnju i njihova uporaba |
US13/535,198 US20120283255A1 (en) | 2005-04-29 | 2012-06-27 | Urea derivatives, methods for their manufacture, and uses therefor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504360 | 2005-04-29 | ||
FR0504360A FR2885129B1 (fr) | 2005-04-29 | 2005-04-29 | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/535,198 Division US20120283255A1 (en) | 2005-04-29 | 2012-06-27 | Urea derivatives, methods for their manufacture, and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006117211A2 WO2006117211A2 (fr) | 2006-11-09 |
WO2006117211A3 true WO2006117211A3 (fr) | 2007-01-11 |
Family
ID=35311522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/004166 WO2006117211A2 (fr) | 2005-04-29 | 2006-04-24 | Derives d'uree, procedes pour leur fabrication et utilisations de ces derives |
Country Status (25)
Country | Link |
---|---|
US (2) | US8247412B2 (fr) |
EP (2) | EP1874765B1 (fr) |
JP (1) | JP4995189B2 (fr) |
KR (1) | KR20080003380A (fr) |
CN (1) | CN101238120A (fr) |
AR (1) | AR056991A1 (fr) |
AT (1) | ATE548368T1 (fr) |
AU (1) | AU2006243328B2 (fr) |
BR (1) | BRPI0611025A2 (fr) |
CA (1) | CA2605008A1 (fr) |
CR (1) | CR9469A (fr) |
CY (1) | CY1112960T1 (fr) |
DK (1) | DK1874765T3 (fr) |
EA (1) | EA200702375A1 (fr) |
ES (1) | ES2384052T3 (fr) |
FR (1) | FR2885129B1 (fr) |
HR (1) | HRP20120424T1 (fr) |
IL (1) | IL186854A0 (fr) |
NO (1) | NO20076145L (fr) |
PL (1) | PL1874765T3 (fr) |
PT (1) | PT1874765E (fr) |
TW (1) | TW200714598A (fr) |
UY (1) | UY29510A1 (fr) |
WO (1) | WO2006117211A2 (fr) |
ZA (1) | ZA200708871B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2885129B1 (fr) | 2005-04-29 | 2007-06-15 | Proskelia Sas | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |
US7875609B2 (en) | 2005-11-25 | 2011-01-25 | Galapagos Sasu | Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them |
CA2648939C (fr) * | 2006-04-20 | 2014-07-08 | Amgen Inc. | Formules d'emulsions stables |
GB0613674D0 (en) * | 2006-07-10 | 2006-08-16 | Proskelia Sas | Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
AU2008233088B2 (en) | 2007-03-30 | 2013-09-26 | Amgen Inc. | Calcimimetic compounds for use in the treatment of bowel disorders |
EP2156846B1 (fr) * | 2007-05-08 | 2014-08-13 | Ajinomoto Co., Inc. | Agent prophylactique ou thérapeutique contre la diarrhée |
JP5504484B2 (ja) * | 2007-07-10 | 2014-05-28 | アムジエン・インコーポレーテツド | ウレア誘導体および関連ジアミン、これらの製造方法および使用 |
WO2010104882A1 (fr) | 2009-03-10 | 2010-09-16 | Amgen Inc. | Procédés de modulation de la motilité des spermatozoïdes |
WO2013138753A1 (fr) | 2012-03-16 | 2013-09-19 | Fox Chase Chemical Diversity Center, Inc. | Promédicaments de riluzole et leur méthode d'utilisation |
US9663529B2 (en) | 2013-07-02 | 2017-05-30 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
TW201506024A (zh) | 2013-07-02 | 2015-02-16 | 必治妥美雅史谷比公司 | 作為有效rock抑制劑的三環甲醯胺衍生物 |
CN107567438B (zh) * | 2015-03-03 | 2021-06-29 | 拜尔哈文制药股份有限公司 | 利鲁唑前药及其用途 |
CN106946851B (zh) * | 2017-03-14 | 2019-11-12 | 牡丹江医学院 | 一种用于预防和治疗肾结石的药物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001000576A1 (fr) * | 1999-06-29 | 2001-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Uree-peptoides de type indole et indazole utilises en tant qu'antagonistes du recepteur de thrombine |
WO2002059102A2 (fr) * | 2001-01-26 | 2002-08-01 | Aventis Pharma S.A. | Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL31574A0 (en) | 1968-02-13 | 1969-04-30 | Ciba Ltd | Use of certain ureas for combating weeds |
US3897242A (en) | 1968-02-13 | 1975-07-29 | Ciba Geigy Ag | Use of 1-(3-chloro-4-methylphenyl)-3,3-dimethylurea in wheat and barley crops |
JPS58109464A (ja) | 1981-12-23 | 1983-06-29 | Nippon Paint Co Ltd | アミノ酸化合物、その製法ならびに触媒 |
US4579947A (en) | 1983-06-16 | 1986-04-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted phenylalkylpiperazinylpropyl (ureas or thioureas) useful for treatment of immunological, inflammatory and allergic disorder |
US4594373A (en) | 1984-02-09 | 1986-06-10 | American Cyanamid Company | Curable epoxy resin compositions |
US4521583A (en) | 1984-02-09 | 1985-06-04 | American Cyanamid Company | Curable epoxy resin compositions |
FR2601363B1 (fr) * | 1986-07-08 | 1988-10-21 | Synthelabo | (dimethylamino)-2 ethyl) ((((methylthio)-2 phenyl) (phenylmethyl)amino)-2 oxo-2 ethyl) carbamates ou urees, leur preparation et leur application en therapeutique. |
US5242947A (en) | 1988-02-10 | 1993-09-07 | New York University | Use of polyamines as ionic-channel regulating agents |
DD298412A5 (de) | 1989-04-28 | 1992-02-20 | ������@���Kk�� | Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele |
US5227397A (en) | 1989-04-28 | 1993-07-13 | Pfizer Inc. | Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
AU5957390A (en) | 1989-07-03 | 1991-02-06 | New York University | Use of polyamines as ionic-channel regulating agents |
US5153226A (en) | 1989-08-31 | 1992-10-06 | Warner-Lambert Company | Acat inhibitors for treating hypocholesterolemia |
AU662309B2 (en) | 1990-11-19 | 1995-08-31 | Monsanto Company | Retroviral protease inhibitors |
US5312928A (en) | 1991-02-11 | 1994-05-17 | Cambridge Neuroscience | Calcium channel antagonists and methodology for their identification |
US6011068A (en) | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
EP0724561B1 (fr) | 1991-08-23 | 2004-04-14 | Nps Pharmaceuticals, Inc. | Arylalkylamines agissant sur les recepteurs du calcium |
US6031003A (en) | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
KR100290516B1 (ko) | 1992-05-20 | 2001-09-17 | 죤 에이치. 뷰센 | 레트로바이러스프로테아제억제인자의합성에유용한중간생성물의제조방법 |
DE69334250D1 (de) | 1992-12-29 | 2009-01-29 | Abbott Lab | Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern |
JPH0841006A (ja) | 1994-08-05 | 1996-02-13 | Nisshin Flour Milling Co Ltd | ジウレア誘導体 |
ATE287390T1 (de) | 1994-10-21 | 2005-02-15 | Nps Pharma Inc | Kalzium-rezeptor aktive verbindungen |
CA2180021A1 (fr) | 1994-11-04 | 1996-05-17 | Yoichi Kawashima | Nouveau derive de 1,3-dialkyluree ayant un groupe hydroxyle |
DE69528197T2 (de) | 1994-12-14 | 2003-06-05 | Santen Pharmaceutical Co Ltd | Neue 1,3-dialkylharnstoff-derivate |
JP3306571B2 (ja) | 1995-06-28 | 2002-07-24 | 参天製薬株式会社 | エンドセリン変換酵素阻害剤 |
CA2197364A1 (fr) | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Compose phenolique et methode de preparation |
JPH10195037A (ja) | 1996-02-15 | 1998-07-28 | Tanabe Seiyaku Co Ltd | フェノール誘導体 |
NZ332068A (en) | 1996-04-09 | 2001-03-30 | Smithkline Beecham | Alpha, alpha-disubstituted arylalkylamine derivatives as calcilytic compounds |
JP2003524574A (ja) | 1997-08-05 | 2003-08-19 | ノボ ノルディスク アクティーゼルスカブ | 2,5−及び3,5−二置換アニリン誘導体、その調製及び使用 |
JPH11139969A (ja) | 1997-08-07 | 1999-05-25 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
US6221913B1 (en) | 1998-01-21 | 2001-04-24 | Zymogenetics, Inc. | Dialkyl ureas as calcitonin mimetics |
IL144910A0 (en) | 1999-04-15 | 2002-06-30 | Bristol Myers Squibb Co | Cyclic compounds and pharmaceutical compositions containing the same |
FR2809396B1 (fr) | 2000-05-24 | 2005-10-14 | Centre Nat Rech Scient | Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation |
FR2812875B1 (fr) | 2000-08-08 | 2003-12-12 | Centre Nat Rech Scient | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
US6598746B2 (en) * | 2001-09-13 | 2003-07-29 | Washburn Graphics, Inc. | Display carton having an internally reinforced hanger panel |
TW200412956A (en) | 2002-09-30 | 2004-08-01 | Schering Corp | Methods for treating disorders of calcium homeostasis |
JP2005336173A (ja) * | 2004-04-27 | 2005-12-08 | Santen Pharmaceut Co Ltd | 骨粗鬆症治療剤 |
PT1757582E (pt) | 2004-05-28 | 2016-03-04 | Mitsubishi Tanabe Pharma Corp | Arilalquilaminas e processo para a sua produção |
FR2885129B1 (fr) | 2005-04-29 | 2007-06-15 | Proskelia Sas | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |
CA2608957C (fr) | 2005-05-19 | 2013-12-10 | Astellas Pharma Inc. | Derive de pyrrolidine ou son sel |
US7875609B2 (en) | 2005-11-25 | 2011-01-25 | Galapagos Sasu | Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them |
GB0613674D0 (en) | 2006-07-10 | 2006-08-16 | Proskelia Sas | Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
JP5504484B2 (ja) | 2007-07-10 | 2014-05-28 | アムジエン・インコーポレーテツド | ウレア誘導体および関連ジアミン、これらの製造方法および使用 |
-
2005
- 2005-04-29 FR FR0504360A patent/FR2885129B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-24 US US11/919,537 patent/US8247412B2/en not_active Expired - Fee Related
- 2006-04-24 CN CNA2006800145076A patent/CN101238120A/zh active Pending
- 2006-04-24 AT AT06724709T patent/ATE548368T1/de active
- 2006-04-24 BR BRPI0611025A patent/BRPI0611025A2/pt not_active IP Right Cessation
- 2006-04-24 AU AU2006243328A patent/AU2006243328B2/en not_active Ceased
- 2006-04-24 DK DK06724709.8T patent/DK1874765T3/da active
- 2006-04-24 EA EA200702375A patent/EA200702375A1/ru unknown
- 2006-04-24 ES ES06724709T patent/ES2384052T3/es active Active
- 2006-04-24 WO PCT/EP2006/004166 patent/WO2006117211A2/fr active Application Filing
- 2006-04-24 KR KR1020077024941A patent/KR20080003380A/ko not_active Application Discontinuation
- 2006-04-24 JP JP2008508167A patent/JP4995189B2/ja not_active Expired - Fee Related
- 2006-04-24 EP EP06724709A patent/EP1874765B1/fr active Active
- 2006-04-24 PL PL06724709T patent/PL1874765T3/pl unknown
- 2006-04-24 CA CA002605008A patent/CA2605008A1/fr not_active Abandoned
- 2006-04-24 PT PT06724709T patent/PT1874765E/pt unknown
- 2006-04-24 EP EP11002964A patent/EP2354137A1/fr not_active Withdrawn
- 2006-04-26 AR ARP060101666A patent/AR056991A1/es unknown
- 2006-04-26 TW TW095114960A patent/TW200714598A/zh unknown
- 2006-04-28 UY UY29510A patent/UY29510A1/es not_active Application Discontinuation
-
2007
- 2007-10-16 ZA ZA200708871A patent/ZA200708871B/xx unknown
- 2007-10-23 CR CR9469A patent/CR9469A/es unknown
- 2007-10-23 IL IL186854A patent/IL186854A0/en unknown
- 2007-11-28 NO NO20076145A patent/NO20076145L/no not_active Application Discontinuation
-
2012
- 2012-05-17 HR HRP20120424TT patent/HRP20120424T1/hr unknown
- 2012-06-06 CY CY20121100508T patent/CY1112960T1/el unknown
- 2012-06-27 US US13/535,198 patent/US20120283255A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001000576A1 (fr) * | 1999-06-29 | 2001-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Uree-peptoides de type indole et indazole utilises en tant qu'antagonistes du recepteur de thrombine |
WO2002059102A2 (fr) * | 2001-01-26 | 2002-08-01 | Aventis Pharma S.A. | Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation |
Also Published As
Publication number | Publication date |
---|---|
EP1874765A2 (fr) | 2008-01-09 |
PL1874765T3 (pl) | 2012-08-31 |
UY29510A1 (es) | 2006-12-29 |
CN101238120A (zh) | 2008-08-06 |
JP4995189B2 (ja) | 2012-08-08 |
ATE548368T1 (de) | 2012-03-15 |
FR2885129B1 (fr) | 2007-06-15 |
NO20076145L (no) | 2008-01-28 |
AU2006243328A1 (en) | 2006-11-09 |
EP1874765B1 (fr) | 2012-03-07 |
BRPI0611025A2 (pt) | 2016-11-16 |
WO2006117211A2 (fr) | 2006-11-09 |
JP2008539186A (ja) | 2008-11-13 |
FR2885129A1 (fr) | 2006-11-03 |
KR20080003380A (ko) | 2008-01-07 |
US8247412B2 (en) | 2012-08-21 |
PT1874765E (pt) | 2012-05-25 |
AU2006243328B2 (en) | 2011-09-08 |
HRP20120424T1 (hr) | 2012-06-30 |
CR9469A (es) | 2008-03-06 |
EP2354137A1 (fr) | 2011-08-10 |
EA200702375A1 (ru) | 2008-06-30 |
CY1112960T1 (el) | 2016-04-13 |
US20120283255A1 (en) | 2012-11-08 |
IL186854A0 (en) | 2008-02-09 |
US20100240889A1 (en) | 2010-09-23 |
CA2605008A1 (fr) | 2006-11-09 |
DK1874765T3 (da) | 2012-06-18 |
AR056991A1 (es) | 2007-11-07 |
ZA200708871B (en) | 2009-03-25 |
ES2384052T3 (es) | 2012-06-28 |
TW200714598A (en) | 2007-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006117211A3 (fr) | Derives d'uree, procedes pour leur fabrication et utilisations de ces derives | |
WO2006114520A3 (fr) | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation | |
WO2008003766A3 (fr) | Nouveaux composés | |
TW200732323A (en) | Organic compounds | |
WO2007061360A3 (fr) | Nouveau composes | |
WO2004074244A3 (fr) | Composes de pyrimidine | |
TW200716121A (en) | Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists | |
EP1982982A4 (fr) | Nouveau derive de coumarine ayant une activite antitumorale | |
WO2007138472A3 (fr) | Dérivés de la triazolopyridazine | |
WO2007009656A3 (fr) | Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede de fabrication, medicaments contenant ce compose et utilisation | |
WO2007090141A3 (fr) | Composés chimiques | |
WO2006021454A3 (fr) | Derives de pyrimidine | |
WO2006024486A3 (fr) | Derives amide de 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, leur fabrication et leur utilisation en tant qu'agents pharmaceutiques | |
TW200616995A (en) | Novel compounds | |
WO2006021457A3 (fr) | Derives de pyrimidine | |
WO2007083060A3 (fr) | Derives de chalcone a activite antimitotique | |
TW200745084A (en) | Novel compounds | |
TW200702330A (en) | 3,4,5-Substituted piperidines | |
JO2770B1 (en) | Organic compounds | |
TW200639156A (en) | New compounds | |
MX2007008237A (es) | Compuestos de piridina novedosos. | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
MY150497A (en) | New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200604410B (en) | Imidazole derivatives, processes for preparing them and their uses | |
MX2009006010A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 562344 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7863/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2605008 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006243328 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/013079 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 186854 Country of ref document: IL Ref document number: CR2007-009469 Country of ref document: CR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12007502393 Country of ref document: PH Ref document number: 2008508167 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680014507.6 Country of ref document: CN Ref document number: 1020077024941 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006724709 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006243328 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200702375 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 2006724709 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11919537 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0611025 Country of ref document: BR Kind code of ref document: A2 Effective date: 20071029 |